Oramed amends bylaws to streamline written-consent record date, delivery rules

Oramed Pharmaceuticals Incorporated

ORMP

0.00

Oramed adopted Fifth Amended and Restated Bylaws, effective June 25, 2026.
Changes reset the record-date framework for stockholder action by written consent when the board does not set a date, aligning with Delaware law.
Bylaws drop a provision that required additional disclosures from stockholders seeking a record date for written-consent actions.
Written consents must now be delivered within 60 days from the first consent delivered to the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oramed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-073709), on June 30, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.